Insider buying last 90 days
No open-market insider purchases were filed for OHI in the last 90 days.
From Form 4 filings, dated to when each was filed.
Nov 13 close
Omega Healthcare Investors moved this week on third-quarter results and a raised outlook. The company reported funds from operations of $262.1 million, or 82 cents per share, ahead of the average analyst estimate of 81 cents, and raised its full-year 2026 adjusted funds from operations guidance to a range of $3.28 to $3.30 per share. The quarter included $181 million in transactions covering five US senior living communities and six UK care homes, along with the transition of Florida skilled nursing facilities to a new operator at higher rent. Occupancy reached 82.7%, EBITDAR coverage improved to 1.67x, and leverage fell to 3.1x. Separate coverage noted an average price target of $49.93 from a group of analysts holding an average "Hold" rating, while filings showed mixed fund activity in the stock.
OHI closed at $48.83, up 1.3%, with price sitting above both the 50-day average of $46.34 and the 200-day average of $46.73. The GekkoIndex reading stands at 47.8, placing the stock in the Neutral zone after a five-point change of -6.2. Price remains 27.1% below Gekko Fair Value of $67.
The next earnings date is 3 February 2027, 85 days out, beyond a typical 20-trading-day holding period. No insider, Congress, or unusual options activity appears in the recent windows. Seasonality over five years shows an average 20-trading-day return of -1.6% from this point, with gains in 1 of those years, a factor worth noting alongside the current consensus target of $51.37.
Written by AI from the Nov 9, 2026 close and checked automatically against the figures on this page.
Omega Healthcare Investors scores 2 supportive, 2 mixed and 1 headwind across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
2 supportive2 mixed1 headwind
Averages disagree
Close $47.05 sits between the 50-day ($46.42) and 200-day ($46.81) averages, or the averages disagree.
See the chart56.3, Neutral
Reading 56.3 is in the Neutral zone.
See the GekkoIndex27.0% below
Price is 27% below Gekko Fair Value (more than 5% below).
See fair valueNo data
No insider, Congress or unusual options activity in the window.
See smart moneyReports in 80 days
Next report Feb 3, 2027, 80 days away — outside a typical 20-trading-day hold.
See earnings−2.5% on average
From this point in the calendar, the next 20 trading days averaged −2.5% over 5 years, rising in 1 of them.
See seasonalityA description of current data, not a recommendation. How this page works
Omega Healthcare Investors closed at $47.05 on Nov 13, 2026, +7.7% over the past year, inside a 52-week range of $42.18 to $52.39.
Use the left and right arrow keys to read daily values.
Put OHI on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Omega Healthcare Investors operates as a real estate investment trust that puts its money into properties used for skilled nursing and assisted living care. Rather than running these facilities itself, it owns the buildings and works with a range of healthcare operators who take on the day-to-day management of the properties.
Most of its arrangements with these operators are structured as triple-net leases, meaning the tenants typically cover costs like taxes, insurance and maintenance on the properties they occupy. Its holdings stretch across every region of the United States, with additional properties located in the United Kingdom.
Omega Healthcare Investors trades under the ticker OHI.
Omega Healthcare Investors’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 56.3, in the Neutral zone, up 6.8 points over five sessions.
Up 6.8 points over five sessions.
Reading for Nov 13, 2026
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 11 | +1.7% | +5.6% | ||
| Accumulation | 187 | +0.7% | +2.4% | ||
| Neutral (current zone) | 433 | +0.2% | +0.8% | ||
| Distribution | 24 | −0.1% | +2.1% | ||
| Selling | 0 | Not available | |||
Average OHI share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +0.9% over 20 days. Past behaviour doesn’t guarantee future results.
Neutral zone: No clear directional signal. About the five zones →
Omega Healthcare Investors trades 27.0% below Gekko Fair Value of $64.44, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what Omega Healthcare Investors shares are worth, recalculated every trading day.
$64.44
Gekko Fair Value, Nov 14, 2026
27.0% Undervalued
At the end of Aug 2026 the price was 33.8% below the estimate.
No open-market insider purchases were filed for Omega Healthcare Investors, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
No open-market insider purchases were filed for OHI in the last 90 days.
From Form 4 filings, dated to when each was filed.
No trades in OHI were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Omega Healthcare Investors has been buying back its own shares.
From company filings.
Omega Healthcare Investors reports on Feb 3, 2027 (80 days away), and beat the EPS estimate in 6 of its last 8 reports.
Feb 3, 2027
80 days away
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Jul 29, 2026 | $0.83 est $0.77 | $262.7M est $267.0M | −2.4% |
| Apr 28, 2026 | $0.48 est $0.49 | $266.9M est $264.1M | +0.1% |
| Feb 4, 2026 | $0.55 est $0.49 | — | +6.1% |
| Oct 30, 2025 | $0.79 est $0.77 | $311.6M est $287.2M | +6.3% |
| Oct 29, 2025 | $0.59 est $0.46 | $311.6M est $287.2M | −0.3% |
| Jul 31, 2025 | $0.77 est $0.75 | $282.5M est $247.9M | +2.9% |
| May 1, 2025 | $0.75 est $0.75 | $276.8M est $236.7M | −5.2% |
| Feb 5, 2025 | $0.74 est $0.41 | $279.3M est $226.2M | +1.2% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Analysts’ average 12-month price target for Omega Healthcare Investors is $51.68, +9.8% from the last close, from 8 firms rating the stock in the last 90 days.
Each firm’s latest rating in the last 90 days: 8 firms.
| Date | Firm | Target | vs price |
|---|---|---|---|
| Nov 11 | UBS | $56 | +19.0% |
| Nov 9 | Bank of America Securities | $49 | +4.1% |
| Nov 4 | Scotiabank | $50 | +6.3% |
| Nov 3 | Wells Fargo | $46 | −2.2% |
| Oct 22 | Citizens JMP | $52 | +10.5% |
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Over the next 20 trading days from Nov 14, Omega Healthcare Investors averaged −2.5% across the last 5 years, rising in 1 of them.
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +0.3% | 3 of 5 |
| Next 10 trading days | −0.6% | 2 of 5 |
| Next 15 trading days | −1.5% | 1 of 5 |
| Next 20 trading days | −2.5% | 1 of 5 |
| Next 30 trading days | −3.2% | 2 of 5 |
For scale, OHI’s typical 20-trading-day move in either direction is about 4%.
Omega Healthcare Investors’s market cap is $14.32B, with a P/E ratio of 19 and revenue of $1.26B over the last twelve months.
Coverage of Omega Healthcare Investors this week reads positive: 3 positive, 2 neutral and 0 negative headlines.
Omega Healthcare Investors’s market cap is $14.32B at the Nov 13, 2026 close of $47.05, with 304.3M shares outstanding. The shares trade on a P/E ratio of 19.
The consensus analyst 12-month price target for Omega Healthcare Investors is $51.68, +9.8% from the last close. Of the 8 firms that rated the stock in the last 90 days, 3 rate it a buy, 3 a hold and 2 a sell. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate Omega Healthcare Investors is undervalued: the Nov 13, 2026 close of $47.05 is 27.0% below Gekko Fair Value of $64.44. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
Omega Healthcare Investors is expected to report on Feb 3, 2027 (80 days away). Analysts expect earnings of $0.51 per share on revenue of $281.4M. Omega Healthcare Investors beat the earnings estimate in 6 of its last 8 reports, moving 3.1% on average across the report.
Omega Healthcare Investors’s 52-week high is $52.39 and its 52-week low is $42.18; it closed at $47.05 on Nov 13, 2026, +7.7% over the past year.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 2 of the 5 items with data read as supportive (fair value and earnings risk), 2 as mixed (trend and gekkoindex) and 1 as a headwind (seasonality). The checklist is a description of current data, not a recommendation.
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,475 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.